Beirne Wealth Consulting Services, LLC Vertex Pharmaceuticals Inc Transaction History

Beirne Wealth Consulting Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $240,764 - $280,643	-1,163 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $23,806 - $31,750	115 Added 10.97%	1,163 $275,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $267,921 - $317,648	1,048 New	1,048 $285,000
Q3 2019 Nov 07, 2019	SELL	$166.23 - $187.09 $191,829 - $215,901	-1,154 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$164.61 - $190.37 $157,696 - $182,374	-958 Reduced 45.36%	1,154 $212,000
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $58,124 - $69,118	-355 Reduced 14.39%	2,112 $389,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $374,761 - $474,182	2,467 New	2,467 $409,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.